Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747862 · ClinicalTrials.gov registry record
Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program
A clinical trial of Attenuated Familial Adenomatous Polyposis and Deleterious Familial Adenomatous Polyposis, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT02747862: Completed study of Attenuated Familial Adenomatous Polyposis and Deleterious Familial Adenomatous Polyposis, sponsored by M.D. Anderson Cancer Center.
NCT02747862 is a study of Attenuated Familial Adenomatous Polyposis and Deleterious Familial Adenomatous Polyposis that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02747862, a study of Attenuated Familial Adenomatous Polyposis and Deleterious Familial Adenomatous Polyposis, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this chart review study is to evaluate the outcomes of subjects with Attenuated Familial Adenomatous Polyposis (AFAP) and Deleterious Familial Adenomatous Polyposis (FAP) who have not undergone surgical resection of the colon. A secondary objective of this study is to compare 1) the colonoscopic and pathology histories including history of ampullary adenoma in the duodenum over family generations, 2) the use of chemopreventive medications, and 3) clinical features of subjects who pursued prophylactic surgical resection of the colon with those that have elected to continue routine colonoscopic surveillance in an effort to better characterize factors (e.g. polyp burden, ampullary adenoma and level of dysplasia, etc) which may influence management decisions.
Primary Outcome
For comparisons between groups, the Mann-Whitney test used.
Conditions Studied
Interventions
- OTHER Chart Review
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2008-02 |
| Est. Completion | 2022-08-17 |
What the finished NCT02747862 record still lists
NCT02747862 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with Attenuated Familial Adenomatous Polyposis appearing as the primary indexed condition, and to 1 intervention - of which Chart Review is the first listed.
NCT02747862 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02747862 about?
NCT02747862 is a clinical study titled "Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program". The primary objective of this chart review study is to evaluate the outcomes of subjects with Attenuated Familial Adenomatous Polyposis (AFAP) and Deleterious Familial Adenomatous Polyposis (FAP) who have not undergone surgical resection of the colon. A secondary objective of this study is to compa...
What is the current status of trial NCT02747862?
This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2008-02. Estimated completion is 2022-08-17.
What conditions does trial NCT02747862 study?
This clinical trial studies the following conditions: Attenuated Familial Adenomatous Polyposis, Deleterious Familial Adenomatous Polyposis.
What interventions are being tested in trial NCT02747862?
The interventions under investigation include: Chart Review (OTHER).
Who is sponsoring clinical trial NCT02747862?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02747862 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia